tirzepatide alzheimer's research versus semaglutide for the prevention of mild cognitive impairment, dementia, and disease in type 2 diabetes: A tirzepatide and dementia Alzheimer's Research:

Circ Res 100:213219

It may be beneficial for patients with conditions that are associated with oxidative stress, such as neurodegenerative diseases, certain cancers, and liver diseases

Our team has seen careers derailed by this

Aetna's Prior Authorization Requirements To get approved for a GLP-1 weight loss medication through Aetna, you typically need to meet all of the following criteria: BMI of 30 or higher , or a BMI of 27 or higher with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea) Documentation of a prior weight management attempt lasting at least 6 months, which can include a structured diet program, behavioral counseling, or a previous medication trial Prescriber must be a licensed physician or advanced practice provider, and some plans require a specialist referral Aetna's clinical policy bulletin (CPB 0784) outlines these requirements in detail